Chicago, ILNCT07387445Now EnrollingIRB Ready

Breast Cancer Early Stage Breast Cancer (Stage 1-3) Clinical Trial in Chicago, IL

Access cutting-edge breast cancer early stage breast cancer (stage 1-3) treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.

Sponsored by University of Illinois at Chicago

Quick Self-Assessment

See if you qualify for this Chicago location

Preparing your pre-screening questions…

Expert Care in Chicago

Access breast cancer early stage breast cancer (stage 1-3) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related breast cancer early stage breast cancer (stage 1-3) treatment provided free

Apply for This Chicago Location

Check if you qualify for this breast cancer early stage breast cancer (stage 1-3) clinical trial in Chicago, IL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Chicago

    Convenient for IL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Chicago site if eligible
  4. 4Begin participation

About This Breast Cancer Early Stage Breast Cancer (Stage 1-3) Study in Chicago

This study is being done to better understand how time restricted eating (eating all food in an 8 hour window) can help a person receiving chemotherapy treatment for breast cancer, stages I-IV. The aim is to find out if time restricted is feasible and acceptable to individuals starting chemotherapy for breast cancer. We will test 3 different eating window options compared to a control group for 24 weeks.

Sponsor: University of Illinois at Chicago

Who Can Participate

Inclusion Criteria

Age 25-99 at time of consent
English language or Spanish language (based on availability of lab interpreters)
ECOG 0 or 1
Breast cancer to meet histologically confirmed Stage I-III or Stage IV with Medical Oncology approval.
Demonstrates adequate organ function (absolute neutrophil count ≥ 1,500/μL).
All screening labs to be obtained within 30 days prior to registration.
Able to provide written informed consent and HIPAA authorization for release of personal health information, via an approved UIC Institutional Review Board (IRB) informed consent form and HIPAA authorization.
Women of childbearing potential must not be pregnant or breast-feeding. A negative serum or urine pregnancy test is required per institutional practice guidelines.
As determined at the discretion of the enrolling physician or protocol designee, ability of the subject to understand and comply with study procedures for the entire length of the study.

Exclusion Criteria

Women with type 1 or insulin dependent type 2 diabetes
Women with BMI \> 45kg/m2 and \< 18.5 kg/m2
Women who are pregnant or nursing. A negative serum or urine pregnancy test is required per institutional practice guidelines.
Shift workers
Women with a history of eating disorders
Enrolled participants with a significant weight loss or weight gain within 3 months of the study (weight gain or loss \>4kg)
Uncontrolled HIV/AIDS or active viral hepatitis
Any prior malignancy \<5 years, chemotherapy within the last year or concurrent malignancy whose natural history or treatment has the potential to interfere with the safety or efficacy assessment of this investigational regimen, as determined by the treating medical oncologist.
Breast cancer recurrence classified by the treating medical oncologist
Any mental or medical condition that prevents the patient from giving informed consent or participating in the trial.
Other major comorbidity, as determined by study PI
Illicit drug use within previous 3 months or excessive use of alcohol (i.e., \> 2 drinks/day)
Currently participating in Weight Watcher's or another weight loss program, including weight loss medication such as GLP-1 medications.
Myocardial infarction
Congestive heart failure
Chronic hepatitis
Chronic pancreatitis
History of solid organ transplantation

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Chicago?

Yes, this clinical trial (NCT07387445) has an active research site in Chicago, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Breast Cancer Early Stage Breast Cancer (Stage 1-3) Treatment Options in Chicago, IL

If you're searching for breast cancer early stage breast cancer (stage 1-3) treatment options in Chicago, IL, this clinical trial (NCT07387445) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer early stage breast cancer (stage 1-3) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all breast cancer early stage breast cancer (stage 1-3) clinical trials near you to find additional studies recruiting in your area.

More Breast Cancer Trials in Chicago, IL

See all breast cancer clinical trials recruiting in Chicago — not just this study.

Browse Breast Cancer Trials in Chicago →

Browse More Trials by Condition

Breast Cancer TrialsAnkylosing Spondylitis TrialsAll Conditions →

Ready to Join in Chicago?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Chicago, IL